Central nervous system effects, such as mental confusion and hallucinations, have been reported with both cimetidine and ranitidine. Elderly patients with renal or hepatic dysfunction are more susceptible to these adverse reactions. We report two cases of reversible mental confusion in elderly patients with mild renal insufficiency following intravenous famotidine therapy, possibly explained by an increased permeability of the blood-brain barrier in patients with decreased renal function.
Get full access to this article
View all access options for this article.
References
1.
ZiemniakJAWelageLSSchentagJJ. Cimetidine and ranitidine. In: EvansWESchentagJJJuskoWJ, eds. Applied pharmacokinetics. Principles of therapeutic drug monitoring. 2nd ed.Spokane: Applied Therapeutics, 1986: 782–825.
2.
MorganMYStambukD. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: Results of a preliminary study. Postgrad Med J1986; 62 (suppl 2):29–37.
3.
BarbaraLCorinaldesiRPorroGB. Famotidine in the management of duodenal ulcer: Experience in Italy. Digestion1985; 32 (suppl 1):24–31.
4.
SimonBDammannHGJakobG. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer. Digestion1985; 32 (suppl 1):32–7.
5.
PaoluziPTorsoliAPorroGB. Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study. Digestion1985; 32 (suppl 1):38–44.
6.
PorroGB. Famotidine in the treatment of gastric and duodenal ulceration: Overview of clinical experience. Digestion1985; 32 (suppl 1):62–9.
7.
McCulloughAJ. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease. Am J Med1986; 81 (suppl 4B):17–24.
8.
SilverstonePH. Ranitidine and confusion (letter). Lancet1984; 1: 1071.
9.
DickinsonRJRoystonCMSSuttonDR. A comparison of famotidine and ranitidine in an elderly population: A multicenter study. Postgrad Med J1986; 62 (suppl 2):63–5.
10.
LyonDT. Efficacy and safety of famotidine in the management of benign gastric ulcers. Am J Med1986; 81 (suppl 4B):33–41.
11.
TakabatakeTOhtaHMaekawaM. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function. Eur J Clin Pharmacol1985; 28: 327–31.
12.
EvansLK. Sundown syndrome in institutionalized elderly. J Am Geriatr Soc1987; 35: 101–8.
13.
KramerMSLeventhalJMHutchinsonTA. An algorithm for the operational assessment of adverse drug reactions. JAMA1979; 242: 623–32.
